Peptide Decoding
New?New to peptides?Start here →
Decoding

Goserelin (Zoladex)_Dosage, benefits & legal status

Also known as Zoladex

Published August 24, 2026 · Updated October 5, 2026

A GnRH agonist given as an implant under the skin rather than an injection.

Hormone suppressionGnRH agonistFDA-approved
DoseSet by the label
FrequencyMonthly or 3-monthly implant
RouteAs an implant under the skin
StatusFDA-approved
CycledSet by the prescription

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Goserelin (Zoladex)?

Plain language first. The technical label stays, but it never stands alone.

Overview

The same hormone shutdown as leuprolide, given as a small pellet under the skin of the belly that dissolves over one or three months.

The technical version

Goserelin acetate, a synthetic GnRH agonist supplied as a biodegradable subcutaneous implant in 1-month and 3-month formulations. FDA-approved 1989. Indications include advanced prostate cancer, breast cancer in premenopausal women, and endometriosis, with additional clinical use for ovarian protection during chemotherapy.

What it's used for

A prescription drug for prostate cancer, breast cancer and endometriosis.

02

How does Goserelin (Zoladex) work?

What it does in the body, and where.

Goserelin differs from leuprolide mainly in how it is delivered, which is not a trivial difference.

  1. 01
    Same desensitisation mechanism
    Continuous GnRH receptor stimulation leads to pituitary downregulation and suppressed sex hormone production, after an initial flare.
  2. 02
    Delivered as a biodegradable implant
    A small cylinder is placed under the skin of the abdomen with a wide-bore needle and releases drug over one or three months. There is nothing to inject daily and nothing to remove.
  3. 03
    It carries a breast cancer indication that leuprolide does not lead with
    Goserelin is used in premenopausal breast cancer to suppress ovarian estrogen production, which is a distinct clinical role within the same drug class.
03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Advanced prostate cancerFDA-approved
  • Breast cancer in premenopausal womenFDA-approved
  • Endometriosis and endometrial thinning before surgeryFDA-approved
  • Protecting ovarian function during chemotherapyClinical use

The published record

Research index

1,916

Papers and trials about Goserelin (Zoladex)

445 papers tagged human · 301 not reviews or lab · 155 clinical trial publications

416 registered trials · 33 with posted results

Furthest stage reached: Approved in the US

Compare this against the whole library →

In animals26
In the lab1
Reviews53
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count. 486 papers and 100 trials indexed in detail.

Goserelin (Zoladex) vial rendering
Compound field notes

At a glance

Four things to know about Goserelin (Zoladex)

01

Evidence

FDA-approved

02

Category

Sexual and hormonal

03

Common vial

Varies

04

Half-life

About 4 hours in men, about 2 in women

04

How much, and do you cycle it?

The range, and whether you take breaks.

Set by the label, monthly or 3-monthly implant. Set by the prescription FDA label

This is a prescription drug. Duration and schedule are set by the label and the prescriber, not by a cycling convention.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

About 4 hours in men, about 2 in womenFDA label

One of the few compounds in the library with a different figure by sex. The label gives about 4.2 hours in men and about 2.3 in women. In patients with impaired kidney function it rises to about 12.1 hours. These figures are for goserelin itself, not for how long the implant keeps releasing it, which runs 28 days.

Source: Zoladex label sections 8.6 and 12.3

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced dose: 3.6 mgFDA label

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW72 / 100 units
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized Goserelin (Zoladex) keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Solubility, computed: 30% charged residues, 30% hydrophobic. Water usually sufficient.

A first-pass rule from peptide manufacturers' guidance. It does not account for disulfide bridges, salt form or how the powder was dried, and it predicts what should be easy rather than what will happen in your vial.

Who should avoid it

Check these before anything else.
  • Pregnancy, where it can cause harm to a developing baby
  • Undiagnosed abnormal vaginal bleeding
  • Known hypersensitivity to GnRH analogs
  • Use outside a prescription, where no label governs the dose

Stop and get help

These are emergencies. Seek care.
  • Worsening bone pain or urinary difficulty in the first weeks, which can reflect the initial flare
  • Signs of an allergic reaction, including facial or throat swelling or trouble breathing
  • Severe pain, swelling or bleeding at the implant site

Common effects

Expected, and usually mild.
  • Hot flushes
  • Reduced libido and sexual function
  • Mood changes
  • Bone density loss with long term use
  • Bruising or pain where the implant is placed

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Goserelin (Zoladex) approved?

And where the numbers on this page come from.

Yes. Goserelin (Zoladex) is FDA approved and available on prescription in the United States.

  • Approval status
    FDA-approved
  • Route
    As an implant under the skin
  • Checked
    24 August 2026
  • Dose
    From the drug label. The manufacturer tested this range and a regulator reviewed it.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

FDA-approved 1989 as a subcutaneous implant for prostate cancer, breast cancer and endometriosis. Prescription only.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 586 records are indexed. Browse the records